Form 4: Hims & Hers Health Chief Marketing Officer Michael Chi Reports Stock Transactions
SEC Form 4 Filing
Michael Chi, Chief Marketing Officer of Hims & Hers Health, Inc., reported the vesting and subsequent sale of shares to cover tax obligations related to restricted stock units.
Summary
- On March 15, 2024, Michael Chi, the Chief Marketing Officer of Hims & Hers Health, Inc., engaged in transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
- Chi acquired 57,151 shares of Class A Common Stock through the vesting of RSUs.
- Simultaneously, 27,535 shares were disposed of to cover tax withholding obligations at a price of $14.63 per share.
- Following these transactions, Chi directly owns 175,705 shares of Class A Common Stock.
- The transactions also involved the vesting of 15,000, 9,357, 16,496, and 16,298 RSUs, which convert to Class A Common Stock.
- These RSUs vest over a 4-year period in quarterly installments, with vesting start dates ranging from June 15, 2022, to June 15, 2023.
Sentiment
Score: 5
Explanation: This Form 4 filing is a neutral event, reflecting standard executive compensation practices and not indicative of any significant positive or negative developments for the company.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding insider transactions but doesn't necessarily reflect the company's overall performance or strategic direction.
Comparison to Industry Standards
- Stock-based compensation, including RSUs, is a common practice among publicly traded companies, especially in the tech and healthcare sectors, to incentivize and retain key employees.
- The vesting schedules described are fairly standard, aligning with industry norms for executive compensation packages.
- Similar companies like Teladoc Health or GoodRx also utilize RSUs as part of their compensation strategy.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, as they relate to executive compensation and tax obligations.
- Employees holding RSUs may be interested in the vesting schedules and associated tax implications.
Key Dates
| Date | Description |
|---|---|
| June 15, 2022 | Initial vesting date for some of the Restricted Stock Units. |
| December 15, 2022 | Initial vesting date for some of the Restricted Stock Units. |
| June 15, 2023 | Initial vesting date for some of the Restricted Stock Units. |
| March 15, 2024 | Date of the reported stock transactions, including RSU vesting and share disposal for tax obligations. |
| March 19, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.